news paper icon

Analyzed News

AbbVie halts late-stage trial for lung cancer drug Rova-T

AbbVie Inc said on Wednesday it had halted enrollment for a late stage trial of Rova-T as a second-line therapy for advanced small-cell lung cancer, following recommendations made by an independent data monitoring committee. [Source]

Publication Date:

Origin: reuters.com

Category: healthNews

Topics: rova-t, cancer, abbvie, lung, trial

Source Link: http://feeds.reuters.com/~r/reuters/healthNews/~3/1B_wkxfoN4k/abbvie-halts-late-stage-trial-for-lung-cancer-drug-rova-t-idUSKBN1O42QK

Related Articles